1652 tests performed with 1597 sites detected as epistasis and 707544 as nearly-neutral.
\scriptsize
\begin{longtable}{lrrrrr}
\toprule
                                     Gene Ontology & $n_{\mathrm{Observed}}$ & $n_{\mathrm{Expected}}$ & Odds ratio & $p_{\mathrm{value}}$ & $e_{\mathrm{value}}$ \\
\midrule
\endhead
\midrule
\multicolumn{6}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
 homophilic cell adhesion via plasma membrane a... &                     166 &                    15.9 &       10.4 &          4e$^{-102}$ &         6.6e$^{-99}$ \\
                                tissue homeostasis &                      85 &                   4.172 &       20.4 &         1.4e$^{-76}$ &         2.3e$^{-73}$ \\
                                   ruffle assembly &                      42 &                   0.275 &      152.9 &         1.6e$^{-72}$ &         2.7e$^{-69}$ \\
                endoplasmic reticulum organization &                      72 &                   3.671 &       19.6 &         3.6e$^{-64}$ &           6e$^{-61}$ \\
                                     cell adhesion &                     249 &                    66.3 &      3.755 &           9e$^{-61}$ &         1.5e$^{-57}$ \\
                                      drug binding &                      88 &                   7.950 &       11.1 &         6.9e$^{-58}$ &         1.1e$^{-54}$ \\
                               calcium ion binding &                     261 &                    75.0 &      3.480 &           2e$^{-57}$ &         3.3e$^{-54}$ \\
                     skeletal system morphogenesis &                      50 &                   1.766 &       28.3 &         1.2e$^{-52}$ &           2e$^{-49}$ \\
                                head morphogenesis &                      50 &                   1.964 &       25.5 &         1.7e$^{-50}$ &         2.7e$^{-47}$ \\
          odontogenesis of dentin-containing tooth &                      53 &                   2.426 &       21.8 &           4e$^{-50}$ &         6.6e$^{-47}$ \\
                                face morphogenesis &                      50 &                   2.268 &       22.0 &         1.4e$^{-47}$ &         2.3e$^{-44}$ \\
                       vitamin D metabolic process &                      66 &                   5.501 &       12.0 &         4.1e$^{-46}$ &         6.8e$^{-43}$ \\
                             lipoprotein transport &                      69 &                   7.348 &      9.391 &         1.5e$^{-41}$ &         2.5e$^{-38}$ \\
                                 endocytic vesicle &                      70 &                   7.794 &      8.981 &         6.2e$^{-41}$ &           1e$^{-37}$ \\
                      substantia nigra development &                      51 &                   3.493 &       14.6 &         4.5e$^{-40}$ &         7.5e$^{-37}$ \\
                               clathrin-coated pit &                      67 &                   8.373 &      8.002 &         2.4e$^{-36}$ &         3.9e$^{-33}$ \\
                             brush border membrane &                      68 &                   8.813 &      7.716 &         6.2e$^{-36}$ &           1e$^{-32}$ \\
          regulation of protein kinase C signaling &                      34 &                   1.397 &       24.3 &         2.5e$^{-34}$ &         4.2e$^{-31}$ \\
 positive regulation of protein kinase A signaling &                      34 &                   1.537 &       22.1 &         5.1e$^{-33}$ &         8.5e$^{-30}$ \\
                         adenylate cyclase binding &                      34 &                   1.676 &       20.3 &           8e$^{-32}$ &         1.3e$^{-28}$ \\
                            apical plasma membrane &                     143 &                    43.5 &      3.289 &         3.1e$^{-31}$ &         5.2e$^{-28}$ \\
 extrinsic component of external side of plasma... &                      38 &                   2.534 &       15.0 &         9.4e$^{-31}$ &         1.6e$^{-27}$ \\
     regulation of Rho protein signal transduction &                      69 &                    11.3 &      6.092 &         1.9e$^{-30}$ &         3.1e$^{-27}$ \\
                    endothelial cell morphogenesis &                      42 &                   3.432 &       12.2 &           2e$^{-30}$ &         3.4e$^{-27}$ \\
    Rho guanyl-nucleotide exchange factor activity &                      69 &                    11.4 &      6.029 &         3.4e$^{-30}$ &         5.5e$^{-27}$ \\
          regulation of protein kinase A signaling &                      34 &                   1.891 &       18.0 &         3.6e$^{-30}$ &         5.9e$^{-27}$ \\
                           collagen type VI trimer &                      30 &                   1.481 &       20.3 &         2.9e$^{-28}$ &         4.7e$^{-25}$ \\
                                  bone development &                      53 &                   7.220 &      7.341 &         1.7e$^{-27}$ &         2.8e$^{-24}$ \\
                     receptor-mediated endocytosis &                      90 &                    21.5 &      4.179 &         2.2e$^{-27}$ &         3.7e$^{-24}$ \\
                                      brush border &                      65 &                    11.4 &      5.685 &         3.2e$^{-27}$ &         5.3e$^{-24}$ \\
                               cobalamin transport &                      35 &                   2.632 &       13.3 &         8.5e$^{-27}$ &         1.4e$^{-23}$ \\
                               apical part of cell &                      70 &                    13.8 &      5.081 &         2.1e$^{-26}$ &         3.5e$^{-23}$ \\
                                 cobalamin binding &                      35 &                   2.773 &       12.6 &         4.5e$^{-26}$ &         7.4e$^{-23}$ \\
       high-density lipoprotein particle clearance &                      35 &                   2.979 &       11.7 &         4.4e$^{-25}$ &         7.2e$^{-22}$ \\
      negative regulation of programmed cell death &                      27 &                   1.399 &       19.3 &         4.4e$^{-25}$ &         7.2e$^{-22}$ \\
         low-density lipoprotein receptor activity &                      47 &                   6.392 &      7.353 &         1.3e$^{-24}$ &         2.1e$^{-21}$ \\
                             COPII vesicle coating &                      52 &                   8.435 &      6.165 &         1.1e$^{-23}$ &         1.8e$^{-20}$ \\
 positive regulation of oligodendrocyte progeni... &                      30 &                   2.298 &       13.1 &         5.3e$^{-23}$ &         8.8e$^{-20}$ \\
          folic acid import across plasma membrane &                      30 &                   2.298 &       13.1 &         5.3e$^{-23}$ &         8.8e$^{-20}$ \\
 positive regulation of lysosomal protein catab... &                      30 &                   2.298 &       13.1 &         5.3e$^{-23}$ &         8.8e$^{-20}$ \\
                  steroid hormone receptor binding &                      30 &                   2.298 &       13.1 &         5.3e$^{-23}$ &         8.8e$^{-20}$ \\
                                            ruffle &                      55 &                   9.938 &      5.534 &           8e$^{-23}$ &         1.3e$^{-19}$ \\
 adenylate cyclase-inhibiting G-protein coupled... &                      35 &                   3.538 &      9.893 &         9.5e$^{-23}$ &         1.6e$^{-19}$ \\
                    neuron projection arborization &                      30 &                   2.349 &       12.8 &         9.7e$^{-23}$ &         1.6e$^{-19}$ \\
                                   plasma membrane &                     576 &                   342.3 &      1.683 &           2e$^{-22}$ &         3.3e$^{-19}$ \\
                       cobalamin metabolic process &                      35 &                   3.684 &      9.500 &         3.4e$^{-22}$ &         5.5e$^{-19}$ \\
                                 protein transport &                     143 &                    54.9 &      2.605 &         5.2e$^{-22}$ &         8.7e$^{-19}$ \\
                     multicellular organism growth &                      53 &                    10.3 &      5.170 &         8.5e$^{-21}$ &         1.4e$^{-17}$ \\
                                    endosome lumen &                      30 &                   2.780 &       10.8 &         9.3e$^{-21}$ &         1.5e$^{-17}$ \\
      ventricular compact myocardium morphogenesis &                      30 &                   2.824 &       10.6 &         1.4e$^{-20}$ &         2.4e$^{-17}$ \\
               secondary heart field specification &                      30 &                   2.898 &       10.4 &         2.8e$^{-20}$ &         4.7e$^{-17}$ \\
                outflow tract septum morphogenesis &                      30 &                   2.916 &       10.3 &         3.3e$^{-20}$ &         5.5e$^{-17}$ \\
                  basal ectoplasmic specialization &                      22 &                   1.219 &       18.1 &         3.7e$^{-20}$ &         6.2e$^{-17}$ \\
                         vitamin metabolic process &                      30 &                   2.938 &       10.2 &         4.1e$^{-20}$ &         6.8e$^{-17}$ \\
                                 chaperone binding &                      45 &                   7.629 &      5.899 &         4.9e$^{-20}$ &           8e$^{-17}$ \\
                                 protein targeting &                      38 &                   5.275 &      7.204 &         5.6e$^{-20}$ &         9.3e$^{-17}$ \\
                                 receptor activity &                      79 &                    22.7 &      3.482 &         9.2e$^{-20}$ &         1.5e$^{-16}$ \\
                  lipoprotein transporter activity &                      34 &                   4.337 &      7.839 &         3.9e$^{-19}$ &         6.5e$^{-16}$ \\
 3-hydroxypalmitoyl-acyl-carrier-protein dehydr... &                      18 &                   0.741 &       24.3 &         6.2e$^{-19}$ &           1e$^{-15}$ \\
 acyl-carrier-protein S-acetyltransferase activity &                      18 &                   0.741 &       24.3 &         6.2e$^{-19}$ &           1e$^{-15}$ \\
       enoyl-acyl-carrier-protein reductase (NADPH &                      18 &                   0.741 &       24.3 &         6.2e$^{-19}$ &           1e$^{-15}$ \\
      acyl-acyl-carrier-protein hydrolase activity &                      18 &                   0.741 &       24.3 &         6.2e$^{-19}$ &           1e$^{-15}$ \\
 3-oxoacyl-acyl-carrier-protein reductase (NADP... &                      18 &                   0.741 &       24.3 &         6.2e$^{-19}$ &           1e$^{-15}$ \\
 acyl-carrier-protein S-malonyltransferase acti... &                      18 &                   0.741 &       24.3 &         6.2e$^{-19}$ &           1e$^{-15}$ \\
 3-oxo-glutaryl-acp methyl ester reductase acti... &                      18 &                   0.741 &       24.3 &         6.2e$^{-19}$ &           1e$^{-15}$ \\
                      fatty acid synthase activity &                      18 &                   0.741 &       24.3 &         6.2e$^{-19}$ &           1e$^{-15}$ \\
 myristoyl-acyl-carrier-protein hydrolase activity &                      18 &                   0.741 &       24.3 &         6.2e$^{-19}$ &           1e$^{-15}$ \\
 palmitoyl-acyl-carrier-protein hydrolase activity &                      18 &                   0.741 &       24.3 &         6.2e$^{-19}$ &           1e$^{-15}$ \\
       enoyl-acyl-carrier-protein reductase (NADPH &                      18 &                   0.741 &       24.3 &         6.2e$^{-19}$ &           1e$^{-15}$ \\
    oleoyl-acyl-carrier-protein hydrolase activity &                      18 &                   0.741 &       24.3 &         6.2e$^{-19}$ &           1e$^{-15}$ \\
 3-hydroxyacyl-acyl-carrier-protein dehydratase... &                      18 &                   0.741 &       24.3 &         6.2e$^{-19}$ &           1e$^{-15}$ \\
 3-oxo-pimeloyl-acp methyl ester reductase acti... &                      18 &                   0.741 &       24.3 &         6.2e$^{-19}$ &           1e$^{-15}$ \\
                        phosphopantetheine binding &                      18 &                   0.741 &       24.3 &         6.2e$^{-19}$ &           1e$^{-15}$ \\
  3-oxoacyl-acyl-carrier-protein synthase activity &                      18 &                   0.741 &       24.3 &         6.2e$^{-19}$ &           1e$^{-15}$ \\
 3-hydroxyoctanoyl-acyl-carrier-protein dehydra... &                      18 &                   0.741 &       24.3 &         6.2e$^{-19}$ &           1e$^{-15}$ \\
                                       endocytosis &                      81 &                    24.6 &      3.295 &         7.4e$^{-19}$ &         1.2e$^{-15}$ \\
 orthogonal dichotomous subdivision of terminal... &                      18 &                   0.755 &       23.9 &         8.4e$^{-19}$ &         1.4e$^{-15}$ \\
 protein localization involved in establishment... &                      18 &                   0.755 &       23.9 &         8.4e$^{-19}$ &         1.4e$^{-15}$ \\
 planar dichotomous subdivision of terminal uni... &                      18 &                   0.755 &       23.9 &         8.4e$^{-19}$ &         1.4e$^{-15}$ \\
 establishment of planar polarity of embryonic ... &                      18 &                   0.755 &       23.9 &         8.4e$^{-19}$ &         1.4e$^{-15}$ \\
  lateral sprouting involved in lung morphogenesis &                      18 &                   0.755 &       23.9 &         8.4e$^{-19}$ &         1.4e$^{-15}$ \\
                               neural tube closure &                      56 &                    12.8 &      4.375 &         1.1e$^{-18}$ &         1.8e$^{-15}$ \\
                                vagina development &                      30 &                   3.394 &      8.840 &         1.9e$^{-18}$ &         3.1e$^{-15}$ \\
                     coronary artery morphogenesis &                      30 &                   3.411 &      8.794 &         2.2e$^{-18}$ &         3.6e$^{-15}$ \\
                                  glycogen granule &                      18 &                   0.804 &       22.4 &         2.4e$^{-18}$ &           4e$^{-15}$ \\
     establishment of body hair planar orientation &                      18 &                   0.840 &       21.4 &           5e$^{-18}$ &         8.3e$^{-15}$ \\
                    pulmonary artery morphogenesis &                      30 &                   3.603 &      8.327 &         9.1e$^{-18}$ &         1.5e$^{-14}$ \\
               positive regulation of neurogenesis &                      30 &                   3.625 &      8.276 &         1.1e$^{-17}$ &         1.8e$^{-14}$ \\
                    pantothenate metabolic process &                      18 &                   0.880 &       20.5 &         1.1e$^{-17}$ &         1.8e$^{-14}$ \\
                  coronary vasculature development &                      30 &                   3.654 &      8.210 &         1.3e$^{-17}$ &         2.2e$^{-14}$ \\
                                 aorta development &                      30 &                   3.676 &      8.161 &         1.5e$^{-17}$ &         2.6e$^{-14}$ \\
                                   lysosomal lumen &                      54 &                    12.8 &      4.235 &         1.7e$^{-17}$ &         2.7e$^{-14}$ \\
                                   Golgi apparatus &                     196 &                    96.8 &      2.025 &         1.8e$^{-17}$ &         2.9e$^{-14}$ \\
                  establishment of planar polarity &                      18 &                   0.949 &       19.0 &         3.9e$^{-17}$ &         6.5e$^{-14}$ \\
                                          lysosome &                      86 &                    29.9 &      2.875 &         1.7e$^{-16}$ &         2.8e$^{-13}$ \\
                        vesicle-mediated transport &                      60 &                    16.6 &      3.625 &           3e$^{-16}$ &           5e$^{-13}$ \\
                cellular response to interleukin-4 &                      18 &                   1.076 &       16.7 &         3.2e$^{-16}$ &         5.3e$^{-13}$ \\
                               metal ion transport &                      31 &                   4.535 &      6.836 &         5.2e$^{-16}$ &         8.5e$^{-13}$ \\
 positive regulation of cellular metabolic process &                      20 &                   1.519 &       13.2 &         6.1e$^{-16}$ &           1e$^{-12}$ \\
                      acetyl-CoA metabolic process &                      20 &                   1.519 &       13.2 &         6.1e$^{-16}$ &           1e$^{-12}$ \\
                    in utero embryonic development &                      55 &                    14.4 &      3.809 &         6.6e$^{-16}$ &         1.1e$^{-12}$ \\
 planar cell polarity pathway involved in neura... &                      18 &                   1.137 &       15.8 &         7.9e$^{-16}$ &         1.3e$^{-12}$ \\
                                     NADPH binding &                      18 &                   1.150 &       15.7 &         9.6e$^{-16}$ &         1.6e$^{-12}$ \\
        guanyl-nucleotide exchange factor activity &                      65 &                    19.7 &      3.301 &         1.4e$^{-15}$ &         2.4e$^{-12}$ \\
               fatty-acyl-CoA biosynthetic process &                      18 &                   1.195 &       15.1 &         1.8e$^{-15}$ &           3e$^{-12}$ \\
                     microtubule minus-end binding &                      23 &                   2.460 &      9.350 &         5.1e$^{-15}$ &         8.4e$^{-12}$ \\
                         hair follicle development &                      22 &                   2.334 &      9.426 &         1.7e$^{-14}$ &         2.7e$^{-11}$ \\
                                    focal adhesion &                      82 &                    31.3 &      2.620 &         9.4e$^{-14}$ &         1.6e$^{-10}$ \\
                        osteoblast differentiation &                      36 &                   7.598 &      4.738 &         1.3e$^{-13}$ &         2.1e$^{-10}$ \\
      negative regulation of BMP signaling pathway &                      30 &                   5.523 &      5.432 &         4.7e$^{-13}$ &         7.7e$^{-10}$ \\
                                   chromatoid body &                      25 &                   3.860 &      6.477 &         9.8e$^{-13}$ &          1.6e$^{-9}$ \\
      G-protein coupled receptor signaling pathway &                     120 &                    57.1 &      2.102 &         1.1e$^{-12}$ &          1.8e$^{-9}$ \\
                auditory receptor cell development &                       8 &                   0.117 &       68.5 &         1.5e$^{-12}$ &          2.5e$^{-9}$ \\
                              transporter activity &                      47 &                    13.6 &      3.468 &         1.8e$^{-12}$ &          2.9e$^{-9}$ \\
                          protein kinase A binding &                      34 &                   7.538 &      4.510 &         2.2e$^{-12}$ &          3.6e$^{-9}$ \\
 heterophilic cell-cell adhesion via plasma mem... &                      29 &                   5.504 &      5.269 &         2.3e$^{-12}$ &          3.8e$^{-9}$ \\
                  regulation of molecular function &                      63 &                    22.4 &      2.816 &           3e$^{-12}$ &            5e$^{-9}$ \\
                  clathrin-coated vesicle membrane &                      34 &                   7.777 &      4.372 &         4.9e$^{-12}$ &          8.1e$^{-9}$ \\
                        retinoid metabolic process &                      39 &                    10.1 &      3.880 &           5e$^{-12}$ &          8.2e$^{-9}$ \\
                       apical protein localization &                      24 &                   3.831 &      6.265 &         5.3e$^{-12}$ &          8.8e$^{-9}$ \\
                    ventricular septum development &                      30 &                   6.163 &      4.868 &         6.6e$^{-12}$ &          1.1e$^{-8}$ \\
                                lysosomal membrane &                      69 &                    26.4 &      2.618 &         7.3e$^{-12}$ &          1.2e$^{-8}$ \\
                         steroid metabolic process &                      36 &                   9.042 &      3.981 &         1.6e$^{-11}$ &          2.6e$^{-8}$ \\
      serine-type endopeptidase inhibitor activity &                      31 &                   6.840 &      4.532 &         1.7e$^{-11}$ &          2.8e$^{-8}$ \\
              regulation of centrosome duplication &                      25 &                   4.429 &      5.644 &         1.7e$^{-11}$ &          2.8e$^{-8}$ \\
                                cell-cell adhesion &                      45 &                    13.5 &      3.335 &         1.8e$^{-11}$ &          2.9e$^{-8}$ \\
                             forebrain development &                      31 &                   6.871 &      4.512 &         1.9e$^{-11}$ &          3.1e$^{-8}$ \\
                     cholesterol metabolic process &                      36 &                   9.239 &      3.897 &         2.8e$^{-11}$ &          4.6e$^{-8}$ \\
                             extracellular exosome &                     300 &                   193.4 &      1.551 &         3.9e$^{-11}$ &          6.5e$^{-8}$ \\
 anchored component of external side of plasma ... &                      21 &                   3.210 &      6.543 &           5e$^{-11}$ &          8.2e$^{-8}$ \\
                               telomerase activity &                      16 &                   1.689 &      9.474 &         5.3e$^{-11}$ &          8.8e$^{-8}$ \\
            RNA-dependent DNA biosynthetic process &                      16 &                   1.689 &      9.474 &         5.3e$^{-11}$ &          8.8e$^{-8}$ \\
                                          endosome &                     110 &                    54.2 &      2.030 &         5.7e$^{-11}$ &          9.3e$^{-8}$ \\
                             extracellular vesicle &                      31 &                   7.280 &      4.258 &         7.6e$^{-11}$ &          1.3e$^{-7}$ \\
                       Golgi to endosome transport &                      20 &                   2.992 &      6.684 &         9.8e$^{-11}$ &          1.6e$^{-7}$ \\
     negative regulation of endopeptidase activity &                      37 &                    10.3 &      3.577 &         1.5e$^{-10}$ &          2.5e$^{-7}$ \\
                             microtubule minus-end &                      14 &                   1.303 &       10.7 &         1.7e$^{-10}$ &          2.8e$^{-7}$ \\
                       regulation of TOR signaling &                      21 &                   3.485 &      6.026 &         2.1e$^{-10}$ &          3.5e$^{-7}$ \\
          anion transmembrane transporter activity &                       8 &                   0.234 &       34.2 &         2.5e$^{-10}$ &          4.2e$^{-7}$ \\
             sodium:bicarbonate symporter activity &                       8 &                   0.234 &       34.2 &         2.5e$^{-10}$ &          4.2e$^{-7}$ \\
                inorganic anion exchanger activity &                       8 &                   0.234 &       34.2 &         2.5e$^{-10}$ &          4.2e$^{-7}$ \\
                      peptidase inhibitor activity &                      31 &                   7.765 &      3.992 &         3.5e$^{-10}$ &          5.7e$^{-7}$ \\
                  anatomical structure development &                      14 &                   1.449 &      9.663 &         6.4e$^{-10}$ &          1.1e$^{-6}$ \\
 negative regulation of cellular component move... &                      21 &                   3.740 &      5.615 &         7.3e$^{-10}$ &          1.2e$^{-6}$ \\
                   Rho protein signal transduction &                      27 &                   6.215 &      4.344 &         7.8e$^{-10}$ &          1.3e$^{-6}$ \\
 isopeptide cross-linking via N6-(L-isoglutamyl... &                      10 &                   0.583 &       17.1 &         9.2e$^{-10}$ &          1.5e$^{-6}$ \\
                                    Golgi membrane &                      99 &                    49.5 &      2.000 &         9.3e$^{-10}$ &          1.5e$^{-6}$ \\
  regulation of DNA double-strand break processing &                       9 &                   0.427 &       21.1 &          1.1e$^{-9}$ &          1.8e$^{-6}$ \\
                                   DNA replication &                       9 &                   0.427 &       21.1 &          1.1e$^{-9}$ &          1.8e$^{-6}$ \\
 single-stranded DNA-dependent ATP-dependent DN... &                       9 &                   0.427 &       21.1 &          1.1e$^{-9}$ &          1.8e$^{-6}$ \\
         ATP-dependent 5'-3' DNA helicase activity &                       9 &                   0.429 &       21.0 &          1.2e$^{-9}$ &          1.9e$^{-6}$ \\
          regulation of microtubule polymerization &                      14 &                   1.530 &      9.153 &          1.3e$^{-9}$ &          2.1e$^{-6}$ \\
         negative regulation of peptidase activity &                      31 &                   8.232 &      3.766 &          1.3e$^{-9}$ &          2.2e$^{-6}$ \\
                           lipid metabolic process &                      99 &                    49.9 &      1.983 &          1.4e$^{-9}$ &          2.3e$^{-6}$ \\
                               homeostatic process &                      21 &                   4.062 &      5.170 &            3e$^{-9}$ &            5e$^{-6}$ \\
                             endoplasmic reticulum &                     174 &                   105.5 &      1.650 &          3.2e$^{-9}$ &          5.4e$^{-6}$ \\
     regulation of actin cytoskeleton organization &                      18 &                   3.021 &      5.959 &          4.7e$^{-9}$ &          7.7e$^{-6}$ \\
               regulation of ERK1 and ERK2 cascade &                      25 &                   5.959 &      4.195 &          6.3e$^{-9}$ &            1e$^{-5}$ \\
                         mammary gland development &                      18 &                   3.090 &      5.825 &          6.6e$^{-9}$ &          1.1e$^{-5}$ \\
       inositol hexakisphosphate 6-kinase activity &                       7 &                   0.236 &       29.7 &          8.5e$^{-9}$ &          1.4e$^{-5}$ \\
                                          U5 snRNP &                      16 &                   2.491 &      6.423 &          1.2e$^{-8}$ &            2e$^{-5}$ \\
                  snRNA-activating protein complex &                      12 &                   1.282 &      9.357 &          1.5e$^{-8}$ &          2.4e$^{-5}$ \\
                          muscle organ development &                      30 &                   8.663 &      3.463 &          1.5e$^{-8}$ &          2.5e$^{-5}$ \\
    regulation of cholesterol biosynthetic process &                      20 &                   4.069 &      4.915 &          1.6e$^{-8}$ &          2.6e$^{-5}$ \\
                          precatalytic spliceosome &                      17 &                   2.942 &      5.778 &          1.9e$^{-8}$ &          3.1e$^{-5}$ \\
                           inner ear morphogenesis &                      18 &                   3.352 &      5.369 &          2.2e$^{-8}$ &          3.6e$^{-5}$ \\
          anterior/posterior pattern specification &                      21 &                   4.662 &      4.504 &            3e$^{-8}$ &            5e$^{-5}$ \\
                              biosynthetic process &                      19 &                   3.836 &      4.953 &          3.2e$^{-8}$ &          5.2e$^{-5}$ \\
                                       Golgi lumen &                      32 &                    10.1 &      3.184 &          3.4e$^{-8}$ &          5.7e$^{-5}$ \\
 hepatocyte growth factor receptor signaling pa... &                      13 &                   1.708 &      7.612 &            4e$^{-8}$ &          6.6e$^{-5}$ \\
                       basolateral plasma membrane &                      43 &                    16.3 &      2.634 &            4e$^{-8}$ &          6.7e$^{-5}$ \\
         regulation of dendritic spine development &                       9 &                   0.667 &       13.5 &          4.6e$^{-8}$ &          7.6e$^{-5}$ \\
 regulation of small GTPase mediated signal tra... &                      49 &                    20.2 &      2.431 &          5.5e$^{-8}$ &          9.1e$^{-5}$ \\
                             Wnt signaling pathway &                      19 &                   4.027 &      4.718 &          6.6e$^{-8}$ &              0.00011 \\
         protein disulfide oxidoreductase activity &                      17 &                   3.229 &      5.265 &            7e$^{-8}$ &              0.00012 \\
                            male gonad development &                      31 &                   9.849 &      3.148 &          7.1e$^{-8}$ &              0.00012 \\
                     telomerase holoenzyme complex &                      16 &                   2.861 &      5.593 &          7.5e$^{-8}$ &              0.00012 \\
                                        sarcolemma &                      32 &                    10.5 &      3.050 &          8.8e$^{-8}$ &              0.00015 \\
       inositol hexakisphosphate 3-kinase activity &                       7 &                   0.344 &       20.4 &            1e$^{-7}$ &              0.00017 \\
        inositol heptakisphosphate kinase activity &                       7 &                   0.344 &       20.4 &            1e$^{-7}$ &              0.00017 \\
       inositol hexakisphosphate 5-kinase activity &                       7 &                   0.344 &       20.4 &            1e$^{-7}$ &              0.00017 \\
         inositol hexakisphosphate kinase activity &                       7 &                   0.344 &       20.4 &            1e$^{-7}$ &              0.00017 \\
 inositol diphosphate tetrakisphosphate kinase ... &                       7 &                   0.344 &       20.4 &            1e$^{-7}$ &              0.00017 \\
       inositol hexakisphosphate 1-kinase activity &                       7 &                   0.344 &       20.4 &            1e$^{-7}$ &              0.00017 \\
                                        inositol-1 &                       7 &                   0.344 &       20.4 &            1e$^{-7}$ &              0.00017 \\
 inositol 5-diphosphate pentakisphosphate 5-kin... &                       7 &                   0.344 &       20.4 &            1e$^{-7}$ &              0.00017 \\
                     transcription factor activity &                      12 &                   1.549 &      7.745 &          1.1e$^{-7}$ &              0.00018 \\
                                   cell projection &                     163 &                   103.1 &      1.581 &          1.1e$^{-7}$ &              0.00018 \\
                                         cognition &                      21 &                   5.097 &      4.120 &          1.3e$^{-7}$ &              0.00021 \\
 negative regulation of protein kinase B signaling &                      21 &                   5.147 &      4.080 &          1.5e$^{-7}$ &              0.00025 \\
                               snRNA transcription &                      12 &                   1.612 &      7.443 &          1.7e$^{-7}$ &              0.00027 \\
                                   anion transport &                       8 &                   0.573 &       14.0 &            2e$^{-7}$ &              0.00033 \\
                            lamellipodium membrane &                      11 &                   1.351 &      8.145 &          2.2e$^{-7}$ &              0.00037 \\
 snRNA transcription from RNA polymerase III pr... &                      13 &                   1.999 &      6.502 &          2.3e$^{-7}$ &              0.00038 \\
                             membrane organization &                      35 &                    12.8 &      2.731 &          2.9e$^{-7}$ &              0.00049 \\
     establishment or maintenance of cell polarity &                      16 &                   3.209 &      4.987 &          3.4e$^{-7}$ &              0.00056 \\
 regulation of cell growth by extracellular sti... &                      10 &                   1.147 &      8.719 &          4.3e$^{-7}$ &              0.00071 \\
              alpha DNA polymerase:primase complex &                       9 &                   0.878 &       10.3 &          4.4e$^{-7}$ &              0.00072 \\
                                hydrolase activity &                      20 &                   5.047 &      3.963 &          4.5e$^{-7}$ &              0.00075 \\
                              microvillus membrane &                      16 &                   3.341 &      4.789 &          5.7e$^{-7}$ &              0.00094 \\
                                 tissue remodeling &                      12 &                   1.891 &      6.347 &          8.5e$^{-7}$ &                0.001 \\
                        endocytic vesicle membrane &                      20 &                   5.372 &      3.723 &          1.2e$^{-6}$ &                0.002 \\
                    behavioral response to cocaine &                       9 &                   0.990 &      9.087 &          1.2e$^{-6}$ &                0.002 \\
          low-density lipoprotein particle binding &                      17 &                   4.088 &      4.158 &          1.7e$^{-6}$ &                0.003 \\
                     protein dimerization activity &                      41 &                    17.6 &      2.326 &          1.7e$^{-6}$ &                0.003 \\
               ATP-dependent RNA helicase activity &                      24 &                   7.616 &      3.151 &          1.9e$^{-6}$ &                0.003 \\
                  detection of mechanical stimulus &                      12 &                   2.048 &      5.860 &          1.9e$^{-6}$ &                0.003 \\
               glycosaminoglycan metabolic process &                      18 &                   4.599 &      3.914 &            2e$^{-6}$ &                0.003 \\
                  regulation of cell morphogenesis &                      14 &                   2.869 &      4.880 &          2.3e$^{-6}$ &                0.004 \\
                                 acrosomal vesicle &                      26 &                   8.849 &      2.938 &          2.5e$^{-6}$ &                0.004 \\
                                 acrosome reaction &                      13 &                   2.554 &      5.090 &          3.3e$^{-6}$ &                0.005 \\
            protein phosphatase inhibitor activity &                      17 &                   4.313 &      3.942 &          3.4e$^{-6}$ &                0.006 \\
                            telomerase RNA binding &                      16 &                   3.857 &      4.148 &          3.4e$^{-6}$ &                0.006 \\
      4-hydroxyphenylpyruvate dioxygenase activity &                       6 &                   0.387 &       15.5 &          3.8e$^{-6}$ &                0.006 \\
              alanylglutamate dipeptidase activity &                       4 &                   0.095 &       42.3 &          3.9e$^{-6}$ &                0.006 \\
                    cytosolic dipeptidase activity &                       4 &                   0.095 &       42.3 &          3.9e$^{-6}$ &                0.006 \\
                      catalytic step 2 spliceosome &                      17 &                   4.362 &      3.897 &          3.9e$^{-6}$ &                0.006 \\
                                 podosome assembly &                       7 &                   0.616 &       11.4 &          4.3e$^{-6}$ &                0.007 \\
                                        melanosome &                      19 &                   5.400 &      3.519 &          4.6e$^{-6}$ &                0.008 \\
 regulation of glutamate uptake involved in tra... &                       8 &                   0.899 &      8.900 &          5.2e$^{-6}$ &                0.009 \\
                                 endosome membrane &                      39 &                    17.3 &      2.261 &          5.7e$^{-6}$ &                0.009 \\
                      lactate biosynthetic process &                       8 &                   0.917 &      8.726 &            6e$^{-6}$ &                0.010 \\
                                   collagen trimer &                      36 &                    15.4 &      2.342 &            6e$^{-6}$ &                0.010 \\
                  interleukin-27 receptor activity &                       6 &                   0.427 &       14.0 &          6.5e$^{-6}$ &                0.011 \\
     negative regulation of fat cell proliferation &                       8 &                   0.928 &      8.620 &          6.6e$^{-6}$ &                0.011 \\
                               locomotory behavior &                      19 &                   5.546 &      3.426 &          6.7e$^{-6}$ &                0.011 \\
                                  response to UV-B &                      10 &                   1.578 &      6.336 &          6.9e$^{-6}$ &                0.011 \\
                            retina layer formation &                       9 &                   1.242 &      7.246 &          6.9e$^{-6}$ &                0.011 \\
                pointed-end actin filament capping &                       7 &                   0.668 &       10.5 &          7.2e$^{-6}$ &                0.012 \\
       negative regulation of phosphatase activity &                      24 &                   8.296 &      2.893 &          7.6e$^{-6}$ &                0.013 \\
 tRNA-type intron splice site recognition and c... &                       7 &                   0.686 &       10.2 &          8.5e$^{-6}$ &                0.014 \\
                 tRNA-intron endonuclease activity &                       7 &                   0.686 &       10.2 &          8.5e$^{-6}$ &                0.014 \\
                  tRNA-intron endonuclease complex &                       7 &                   0.686 &       10.2 &          8.5e$^{-6}$ &                0.014 \\
                   fatty acid biosynthetic process &                      20 &                   6.326 &      3.161 &          1.2e$^{-5}$ &                0.020 \\
                    regulation of intracellular pH &                      11 &                   2.074 &      5.304 &          1.3e$^{-5}$ &                0.021 \\
 biotin-methylmalonyl-CoA-carboxytransferase li... &                       6 &                   0.486 &       12.3 &          1.3e$^{-5}$ &                0.022 \\
                             histone biotinylation &                       6 &                   0.486 &       12.3 &          1.3e$^{-5}$ &                0.022 \\
 biotin-methylcrotonoyl-CoA-carboxylase ligase ... &                       6 &                   0.486 &       12.3 &          1.3e$^{-5}$ &                0.022 \\
     biotin-acetyl-CoA-carboxylase ligase activity &                       6 &                   0.486 &       12.3 &          1.3e$^{-5}$ &                0.022 \\
                             protein biotinylation &                       6 &                   0.486 &       12.3 &          1.3e$^{-5}$ &                0.022 \\
 biotin-propionyl-CoA-carboxylase (ATP-hydrolyz... &                       6 &                   0.486 &       12.3 &          1.3e$^{-5}$ &                0.022 \\
                                response to biotin &                       6 &                   0.486 &       12.3 &          1.3e$^{-5}$ &                0.022 \\
                    biotin-protein ligase activity &                       6 &                   0.486 &       12.3 &          1.3e$^{-5}$ &                0.022 \\
          equatorial microtubule organizing center &                       9 &                   1.359 &      6.622 &          1.4e$^{-5}$ &                0.023 \\
 interphase microtubule nucleation by interphas... &                       9 &                   1.359 &      6.622 &          1.4e$^{-5}$ &                0.023 \\
                           oxidoreductase activity &                       6 &                   0.495 &       12.1 &          1.5e$^{-5}$ &                0.024 \\
    Rac guanyl-nucleotide exchange factor activity &                      12 &                   2.549 &      4.708 &          1.6e$^{-5}$ &                0.027 \\
                    white fat cell differentiation &                       9 &                   1.395 &      6.452 &          1.7e$^{-5}$ &                0.028 \\
             dermatan sulfate biosynthetic process &                       9 &                   1.411 &      6.380 &          1.9e$^{-5}$ &                0.031 \\
          negative regulation of apoptotic process &                      65 &                    36.6 &      1.777 &          1.9e$^{-5}$ &                0.031 \\
                              astrocyte activation &                       7 &                   0.800 &      8.746 &          2.2e$^{-5}$ &                0.037 \\
                            microtubule nucleation &                       9 &                   1.465 &      6.145 &          2.5e$^{-5}$ &                0.041 \\
                                  spectrin binding &                      16 &                   4.558 &      3.510 &          2.6e$^{-5}$ &                0.042 \\
                                    nuclear lamina &                       6 &                   0.551 &       10.9 &          2.6e$^{-5}$ &                0.044 \\
                        condensin core heterodimer &                       7 &                   0.827 &      8.460 &          2.8e$^{-5}$ &                0.046 \\
                                          membrane &                     740 &                   603.4 &      1.226 &          2.8e$^{-5}$ &                0.047 \\
                                tRNA transcription &                       4 &                   0.162 &       24.7 &          2.9e$^{-5}$ &                0.048 \\
                multicellular organism development &                     149 &                   103.3 &      1.442 &            3e$^{-5}$ &                0.049 \\
                                     tRNA splicing &                       7 &                   0.839 &      8.347 &            3e$^{-5}$ &                0.050 \\
                  external side of plasma membrane &                      44 &                    22.1 &      1.995 &            3e$^{-5}$ &                0.050 \\
                                       cell cortex &                      39 &                    18.7 &      2.090 &          3.1e$^{-5}$ &                0.051 \\
             chondroitin sulfate catabolic process &                       9 &                   1.516 &      5.935 &          3.2e$^{-5}$ &                0.053 \\
                                myofibril assembly &                       7 &                   0.854 &      8.193 &          3.4e$^{-5}$ &                0.056 \\
                      extracellular matrix binding &                      16 &                   4.668 &      3.427 &          3.4e$^{-5}$ &                0.056 \\
                                    nuclear matrix &                      28 &                    11.6 &      2.416 &          3.5e$^{-5}$ &                0.058 \\
     negative regulation of type 2 immune response &                       6 &                   0.583 &       10.3 &          3.6e$^{-5}$ &                0.059 \\
                                   sublamina densa &                      10 &                   1.940 &      5.154 &          3.9e$^{-5}$ &                0.064 \\
 negative regulation of phosphoprotein phosphat... &                      17 &                   5.265 &      3.229 &          4.1e$^{-5}$ &                0.067 \\
                              histone modification &                       6 &                   0.603 &      9.953 &          4.3e$^{-5}$ &                0.071 \\
                        collagen catabolic process &                      33 &                    15.0 &      2.203 &          4.5e$^{-5}$ &                0.074 \\
 transcription initiation from RNA polymerase I... &                       4 &                   0.185 &       21.7 &          4.7e$^{-5}$ &                0.078 \\
                         metanephros morphogenesis &                      10 &                   1.990 &      5.026 &          4.8e$^{-5}$ &                0.079 \\
                                           cytosol &                     477 &                   383.7 &      1.243 &            5e$^{-5}$ &                0.083 \\
                                SH3 domain binding &                      34 &                    15.8 &      2.154 &          5.4e$^{-5}$ &                0.089 \\
    trans-Golgi network transport vesicle membrane &                       4 &                   0.191 &       20.9 &          5.4e$^{-5}$ &                0.089 \\
                                midgut development &                       7 &                   0.926 &      7.556 &          5.6e$^{-5}$ &                0.092 \\
 DNA-templated transcriptional preinitiation co... &                       5 &                   0.387 &       12.9 &          5.7e$^{-5}$ &                0.094 \\
          chondroitin sulfate biosynthetic process &                       9 &                   1.642 &      5.480 &          5.9e$^{-5}$ &                0.097 \\
                enteric nervous system development &                      10 &                   2.053 &      4.872 &          6.1e$^{-5}$ &                0.101 \\
                                 neuron remodeling &                       7 &                   0.947 &      7.395 &          6.3e$^{-5}$ &                0.105 \\
           negative regulation of circadian rhythm &                       8 &                   1.288 &      6.212 &          6.4e$^{-5}$ &                0.106 \\
                                   mitotic spindle &                      24 &                   9.546 &      2.514 &          6.7e$^{-5}$ &                0.110 \\
                               trans-Golgi network &                      22 &                   8.385 &      2.624 &          7.2e$^{-5}$ &                0.119 \\
                                hair cycle process &                       9 &                   1.694 &      5.313 &          7.4e$^{-5}$ &                0.123 \\
                           T cell receptor binding &                       5 &                   0.434 &       11.5 &          9.7e$^{-5}$ &                0.160 \\
                              glial cell migration &                       9 &                   1.759 &      5.116 &          9.8e$^{-5}$ &                0.162 \\
                     anion transmembrane transport &                       8 &                   1.376 &      5.816 &               0.0001 &                0.166 \\
                                     wound healing &                      26 &                    11.1 &      2.345 &               0.0001 &                0.170 \\
   regulation of isotype switching to IgG isotypes &                       6 &                   0.713 &      8.414 &              0.00011 &                0.175 \\
             microtubule cytoskeleton organization &                      32 &                    15.1 &      2.124 &              0.00011 &                0.183 \\
                  cellular calcium ion homeostasis &                      27 &                    11.9 &      2.273 &              0.00013 &                0.209 \\
    transcription from RNA polymerase III promoter &                      16 &                   5.359 &      2.986 &              0.00016 &                0.265 \\
                    regulation of vasoconstriction &                       8 &                   1.488 &      5.376 &              0.00017 &                0.280 \\
 negative regulation of transcription regulator... &                       8 &                   1.490 &      5.368 &              0.00017 &                0.283 \\
               regulation of blood vessel diameter &                       6 &                   0.783 &      7.664 &              0.00017 &                0.288 \\
                          mitotic spindle assembly &                      12 &                   3.311 &      3.624 &              0.00019 &                0.308 \\
                             ureteric bud invasion &                       6 &                   0.796 &      7.534 &              0.00019 &                0.315 \\
                    regulation of circadian rhythm &                      15 &                   4.898 &      3.062 &              0.00019 &                0.321 \\
               circadian regulation of translation &                       8 &                   1.520 &      5.265 &              0.00019 &                0.322 \\
                       DNA methylation on cytosine &                       5 &                   0.511 &      9.786 &               0.0002 &                0.334 \\
                       C-5 methylation of cytosine &                       5 &                   0.511 &      9.786 &               0.0002 &                0.334 \\
      DNA (cytosine-5-)-methyltransferase activity &                       5 &                   0.511 &      9.786 &               0.0002 &                0.334 \\
                                    lyase activity &                      27 &                    12.3 &      2.199 &              0.00021 &                0.348 \\
                       sensory perception of sound &                      32 &                    15.7 &      2.044 &              0.00021 &                0.354 \\
               regulation of mitochondrial fission &                       6 &                   0.846 &      7.093 &              0.00026 &                0.432 \\
                                kidney development &                      25 &                    11.1 &      2.244 &              0.00026 &                0.432 \\
                                   kinesin complex &                      18 &                   6.809 &      2.644 &              0.00028 &                0.464 \\
                   Rac protein signal transduction &                       7 &                   1.214 &      5.764 &              0.00028 &                0.468 \\
 negative regulation of NF-kappaB transcription... &                      23 &                   9.955 &      2.310 &               0.0003 &                0.499 \\
                                       microtubule &                      78 &                    50.9 &      1.533 &              0.00032 &                0.533 \\
           inositol phosphate biosynthetic process &                       7 &                   1.241 &      5.639 &              0.00032 &                0.533 \\
            telomere maintenance via recombination &                      17 &                   6.316 &      2.692 &              0.00033 &                0.551 \\
                                         aggresome &                      15 &                   5.200 &      2.885 &              0.00036 &                0.594 \\
               morphogenesis of an epithelial fold &                       4 &                   0.322 &       12.4 &              0.00037 &                0.612 \\
 epidermal growth factor-activated receptor act... &                       4 &                   0.322 &       12.4 &              0.00037 &                0.612 \\
                               multivesicular body &                       4 &                   0.322 &       12.4 &              0.00037 &                0.612 \\
 activation of phospholipase A2 activity by cal... &                       4 &                   0.322 &       12.4 &              0.00037 &                0.612 \\
 negative regulation of cardiocyte differentiation &                       4 &                   0.322 &       12.4 &              0.00037 &                0.612 \\
                     response to hydroxyisoflavone &                       4 &                   0.322 &       12.4 &              0.00037 &                0.612 \\
 positive regulation of nitric oxide mediated s... &                       4 &                   0.322 &       12.4 &              0.00037 &                0.612 \\
                     diterpenoid metabolic process &                       4 &                   0.322 &       12.4 &              0.00037 &                0.612 \\
                 regulation of heart morphogenesis &                       3 &                   0.131 &       23.0 &              0.00037 &                0.615 \\
 mesenchymal to epithelial transition involved ... &                       3 &                   0.131 &       23.0 &              0.00037 &                0.615 \\
 smoothened signaling pathway involved in ventr... &                       3 &                   0.131 &       23.0 &              0.00037 &                0.615 \\
  negative regulation of hair follicle development &                       3 &                   0.131 &       23.0 &              0.00037 &                0.615 \\
                     ventral midline determination &                       3 &                   0.131 &       23.0 &              0.00037 &                0.615 \\
 detection of cell density by contact stimulus ... &                       3 &                   0.131 &       23.0 &              0.00037 &                0.615 \\
                         magnesium ion homeostasis &                       4 &                   0.329 &       12.2 &               0.0004 &                0.661 \\
                                  cadherin binding &                      34 &                    17.7 &      1.918 &              0.00043 &                0.705 \\
                  interleukin-18 receptor activity &                       4 &                   0.336 &       11.9 &              0.00043 &                0.712 \\
           cell surface receptor signaling pathway &                      47 &                    27.3 &      1.724 &              0.00043 &                0.716 \\
                                  response to UV-A &                       4 &                   0.342 &       11.7 &              0.00046 &                0.766 \\
                             RNA helicase activity &                       7 &                   1.331 &      5.257 &              0.00049 &                0.803 \\
            positive regulation of bone resorption &                       9 &                   2.198 &      4.095 &              0.00049 &                0.807 \\
                                    biotin binding &                       8 &                   1.751 &      4.568 &              0.00049 &                0.813 \\
                               tropomyosin binding &                       7 &                   1.347 &      5.196 &              0.00052 &                0.859 \\
            phosphatidylinositol metabolic process &                      10 &                   2.701 &      3.703 &              0.00053 &                0.869 \\
                                 tethering complex &                       6 &                   0.970 &      6.187 &              0.00053 &                0.877 \\
 positive regulation of production of miRNAs in... &                       4 &                   0.356 &       11.2 &              0.00053 &                0.882 \\
         interleukin-18-mediated signaling pathway &                       4 &                   0.356 &       11.2 &              0.00053 &                0.882 \\
       defense response to Gram-positive bacterium &                      17 &                   6.599 &      2.576 &              0.00054 &                0.892 \\
 stimulatory C-type lectin receptor signaling p... &                      13 &                   4.288 &      3.032 &              0.00055 &                0.904 \\
                                  neuron migration &                      22 &                   9.799 &      2.245 &              0.00058 &                0.959 \\
\end{longtable}
